In the pharmaceutical industry, Chloroquine Phosphate is a 4-aminoquinoline derivative. As a pharmacist and manufacturer, I categorize this as a “Long-Persistence” antimalarial. Its timing is critical because its exceptionally long half-life (30–60 days) allows for infrequent dosing in prevention, but requires a strict loading-dose protocol for treatment.
At your WHO-GMP facility in Mumbai, you likely manufacture the standard 250 mg tablets (containing 150 mg base).
1. Timing for Malaria Prophylaxis (Prevention)
For travelers or residents in areas where Chloroquine is still effective (non-resistant zones):
Frequency: Once a week, on the same day each week.
Duration: Start 1–2 weeks before entering the endemic area, continue weekly during the stay, and for 4 weeks after leaving.
With Food: Always take it with a meal or a glass of milk to minimize the most common side effect: gastrointestinal upset.
2. Timing for Malaria Treatment (Acute Attack)
If being used for treatment (where sensitivity is confirmed), the timing follows a “Front-Loaded” schedule over 3 days:
| Day | Timing | Typical Adult Dose (250mg salt / 150mg base) |
| Day 1 | Initial Dose | 4 Tablets (600 mg base) |
| Day 1 | 6 Hours Later | 2 Tablets (300 mg base) |
| Day 2 | 24 Hours after 1st dose | 2 Tablets (300 mg base) |
| Day 3 | 48 Hours after 1st dose | 2 Tablets (300 mg base) |
3. Timing for Rheumatoid Arthritis or Lupus
Frequency: Usually once daily at the same time.
Pharmacist’s Tip: It may take several weeks to see the full anti-inflammatory effect.
Mechanism: The Heme-Detoxification Blockade
Chloroquine works by interfering with the parasite’s ability to survive inside human red blood cells.
Vacuole Accumulation: Chloroquine is a weak base; it concentrates heavily in the acidic food vacuole of the Plasmodium parasite.
Heme Poisoning: The parasite digests hemoglobin, releasing toxic Heme. Normally, the parasite converts this into non-toxic Hemozoin. Chloroquine blocks this conversion.
Lysis: The buildup of free heme destroys the parasite’s internal membranes, leading to its death.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Salt vs. Base” USP: On your digital platforms, always clearly state both the Salt weight (250 mg) and the Base equivalent (150 mg). This technical clarity prevents dosing errors and is a major trust-builder with international Ministry of Health buyers.
Stability for Zone IVb: Chloroquine is relatively stable, but we utilize Alu-Alu blister packaging to protect against the high humidity of tropical export markets, ensuring a 36-month shelf life.
Niche Market Strategy: While resistance is high in many areas, Chloroquine remains the gold standard for P. vivax and P. malariae. Positioning your product specifically for these species on your marketplace can attract specialized B2B inquiries.
Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in regions like Central America and parts of the Middle East where Chloroquine sensitivity remains.